Hepatitis C Screening For Baby Boomers in Primary Care. Nicole Mesick DO, RD NHAFP Conference May 18 th, 2018

Size: px
Start display at page:

Download "Hepatitis C Screening For Baby Boomers in Primary Care. Nicole Mesick DO, RD NHAFP Conference May 18 th, 2018"

Transcription

1 Hepatitis C Screening For Baby Boomers in Primary Care Nicole Mesick DO, RD NHAFP Conference May 18 th, 2018

2 Disclosures No disclosures

3 Objectives Recognize the importance of diagnosing Hepatitis C (HCV) Explain how to counsel regarding HCV Review HCV recommendations for screening Determine how we can apply this knowledge to improve screening rates

4 Introduction million people in the world have HCV infection An estimated million people in the United States have chronic HCV

5 Introduction 5 HCV infection is a major cause of chronic liver disease and cirrhosis Transmission through blood, bodily fluids Screening is recommended for all adults with high risk of infection and one time screening for those born between

6 Hepatitis C Virus 5

7 Implications of Chronic HCV 6 Fibrosis Cirrhosis Hepatocellular Carcinoma (with cirrhosis) Fibrosis Chronic HCV infection can lead to the development of fibrous scar tissue within the liver HCC Cancer of the liver can develop after years of chronic HCV infection Cirrhosis Over time, fibrosis can progress, causing severe scarring of the liver, restricted blood flow, impaired liver function, and eventually liver failure

8 Hepatitis C for the Primary Care Provider

9 Who should be screened IVDU Persistently abnormal ALT levels History of Blood Transfusions before 1987 Everyone born from 1945 through 1965 Recipients of organ transplants prior to 1992 Long-term hemodialysis Persons with hemophilia HIV positive persons Occupational Exposure Surgery before implementation of universal precautions Children born to HCV positive women Incarceration Unregulated Tattoos

10 Screening U.S. Preventative Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommend: Periodic HCV screening for all adults at high risk One-time screening in adults born between

11 100 HCV infected individuals

12 Baby Boomers ,3 Account for 75% of HCV in the US Only 50% are aware they are infected Have a 5x increased prevalence than other adults

13 1.6 Estimated Prevalence by Age Group Number with chronic HCV (millions) < s 1930s 1940s 1950s 1960s 1970s 1980s Birth Year Group

14 100 Baby Boomers with HCV

15

16 A Public Health Problem

17 A Public Health Problem

18 Literature Review-screening programs 4 Hospital Based Screening program Lessons from implementing HIV screening Provider/staff education EMR integration with exclusions Anti-HCV antibody test with reflex HCV RNA Admission order sets Patient education Subjects Baby boomer HCV screening Majority Hispanic Population 498 bed safety- net academic affiliated hospital South Texas 2 year implementation ( ) Interventions Opt-out consent (admission packet flyers and posters) HCV counselor for positive results Community health worker arranged linkage to care

19 Hospital Based Results 4 Mean age 56.4 years 4.2% of all eligible patients were chronically infected with HCV

20 Hospital Based Primary Care 2 Pre-intervention-baseline measurements Prospective interventional study Maintenance phase Mount Sinai Hospital Internal Medicine primary care practice November

21 Hospital Based Primary Care 2 Results: HCV positive-3.3% Screening increased- 55% to 75% Percentage of patients linked to care and attended first appointment -77%

22 Primary Care Screening 13 Developed Best Practice Advisory (BPA) in EHR to prompt for screening among baby boomers Subsequent workflow for care management of newly diagnosed patients Baseline screening consisted of 3 years prior to BPA This study did NOT have reflex HCV RNA testing Subjects All baby boomers who had one visit during prior 3 years in PCP clinic 13 clinics within 30 miles of Ann Arbor, Michigan 3 month period

23 Primary Care Screening 13 Results Increased screening by 5-fold Successful linkage to care and curative treatment EHR design eliminated work flow burden placed on PCPs to remember recommendation during visit and locate previous testing

24 HCV positive-what next? 8 Provide info on HCV infection Evaluate support- behavioral health services Counsel Patients about reducing risk of transmission Do not donate blood, body organs, other tissue, or semen Do not share personal items that might have small amounts of blood (toothbrushes, razors, nailgrooming equipment, needles) and cover cuts and wounds HCV is not spread by hugging, kissing, food or water, sharing utensils, or casual contact If in short term or multiple relationships, use latex condoms. No condom use is recommended for longterm monogamous couples (risk of transmission is very low)

25 HCV positive-what next? 8 Brief alcohol usage screen and intervention Goal is reducing or discontinuing alcohol consumption Alcohol increased the development of cirrhosis in those with HCV with an odds ration of Abstinence from substances

26 HCV positive-what next? 8 Referral to specialist- Infectious Disease/Gastroenterology Coordination, labs and imaging prior to referral Insurance Coverage or financial assistance

27 HCV positive-what next? 8 Weight management Consider weight management or losing weight Counsel on following a healthy diet and staying physically active. Those with obesity and metabolic syndrome who have underlying insulin resistance are more prone to nonalcoholic fatty liver disease which can accelerate fibrosis progression in HCV.

28 HCV positive-what next? 8 Vaccination Test for HIV antibody and Hepatitis B Co-infection with Hepatitis B virus or HIV is associated with poorer prognosis Hepatitis A and B vaccine Twinrix vaccine- 3 injections If Cirrhosis: Pneumovax and flu vaccine Screening for HCC every 6 months with liver ultrasound

29 Screening and linkage to care 11 One-time testing is estimated to: identify 800,000 infections with linkage to care and treatment, avert more than 120,000 HCV-related deaths save $1.5 $7.1 billion in liver disease related costs

30 Treatment All patients with chronic HCV should be treated Goal is to reduce all cause mortality and liver associated complications

31 When and Whom to treat 16 All HCV infected individuals Best initiated early in course of disease Immediate benefit to those at highest risk of liver-related complications Accurate assessment of liver fibrosis helps to predict progression

32 Strategies to improve screening

33 Family Health Center Baby Boomer Screening N= % N=3290 baby boomers Screened

34 Family Health Center N= % N=482 Total Screened Chronic HCV

35 What populations are we currently screening? IV drug users Hx blood transfusion HIV + Long term hemodialysis Incarceration Everyone Other

36 Barriers to discussing screening N=73 Not important No prompt in EMR Unclear on current recommendations Not applicable Time constraints Never really think about it

37 Increasing screening HCV informational posters around the clinic HCV handouts available in clinic Provider education Recall letters with CDC fact sheet Cerner implementation Behavioral Health Support

38 Family Health Center screening Conducted Grand Rounds presentation regarding screening and interventions Recall letters sent to eligible non-screened patients on physician panel Physician panel pilot statistically significantly increased screening from 21% to 48% (p<.05) Electronic medical record transition did impede data requisition and monthly interval data collection.

39 FHC screening

40 Screening Recommendations Annual Testing: persons who inject drugs HIV-seropositive men who have unprotected sex with men Once obtained SVR: Without fibrosis-require no additional follow up Advanced fibrosis-hcc screening twice yearly Assessment for reoccurrence only with ongoing risk, HCV RNA

41 Resources for providers and patients

42

43 Hepatitis C Commercial

44 Conclusion HCV recognition is important It is imperative that we feel confident in counseling regarding HCV We have resources available to assist in guiding patients and ourselves through the diagnosis

45 References 1. Easterbrook PJ, Who to test and how to test for chronic hepatitis c infection WHO testing gyidance for low and middle income countries. Journal of hepatology. 2016; 65 (1) S46-S Goel A, Sanchez J, Paulino L, et al. A systemic model improves hepatitis C virus birth cohort screening in hospital based primary care. J Viral Hepatitis. 2017; Rein DB, Smith BD, Wittenborn JS, et. Al, The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings. 4. Turner BJ, Taylor BS, Hanson JT, et al. Implementing hospital based baby boomer hepatitis c virus screening and linkage to care: strategies, results and costs. Journal of Hospital Medicine. 2015; 10 (8) Wilkins T, Akhtar M, Gititu E. Diagnosis and management of hepatitis C. American Family Physician. 2015; 91(12): Graham CS. National virus hepatitis roundtable HCV baby boomer screening and linkage to care program Ly KN, Xing J, Klevens M et al. The increasing burden of mortality from viral hepatitis in the United Statses between 1999 and Ann Intern Med. 2012; 156: (get this article through library) 8. Centers for Disease Control and Prevention MMWR. Recommendations for the identification of chronic Hepatitis C Virus infection among persons born between 1945 and Huffman MM, Mounsey AL. Hepatitis C for primary care physicians. JABFM. 2014;27 (2): Cantab AC-GBAH. Hepatitis C (HCV) testing for baby boomers: an interview with Dr. Donald Jensen, Director, Center for Liver Diseases, University of Chicago. News-Medical.net. Published August 3, Accessed November 5, Coffin PO, Reynolds A. Ending hepatitis C in the United States: the role of screening. Hepatic Medicine. 2014; 6: Morgan RL, Baack B, Smith BD, et al. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma. Annals of Internal Medicine. 2013; 158 (5): Konerman MA, Thomson M, Gray K, et al. Impact of an Electronic Health Record Alert in Primary Care on Increasing Hepatitis C Screening and Curative Treatment for Baby Boomers. Hepatology. 2017;00(00): Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During (2012, August 17). Retrieved November 05, 2017, from Andrade LJ, D'Oliveira A, Melo RC, et al. Association Between Hepatitis C and Hepatocellular Carcinoma. Retrieved from (2009). 16. Chung, R. T., Davis, G. L., Jensen, et al (2015), Hepatitis C guidance: AASLD IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology, 62: doi: /hep.27950

46 Questions? Comments?

HCV in the Latino Community -Epidemiology, Natural History, Risk Factors, Screening and Diagnosis

HCV in the Latino Community -Epidemiology, Natural History, Risk Factors, Screening and Diagnosis HCV in the Latino Community -Epidemiology, Natural History, Risk Factors, Screening and Diagnosis Wari Allison MD, PhD Assistant Professor/Research Dept. of Medicine/Infectious Disease Medical Director

More information

Recommendations for Hepatitis C Screening

Recommendations for Hepatitis C Screening Hepatitis C Online PDF created June 16, 2018, 9:14 am Recommendations for Hepatitis C Screening This is a PDF version of the following document: Module 1: Screening and Diagnosis of Hepatitis C Infection

More information

Improving Access & Linkage to Care in Underserved Populations & Baby Boomers

Improving Access & Linkage to Care in Underserved Populations & Baby Boomers Improving Access & Linkage to Care in Underserved Populations & Baby Boomers Lesley Miller MD Medical Director, Grady Liver Clinic Associate Professor of Medicine Division of General Medicine and Geriatrics

More information

What is Hepatitis C Virus (HCV)?

What is Hepatitis C Virus (HCV)? HEPATITIS C VIRUS (HCV) What is Hepatitis C Virus (HCV)? Hepatitis is an inflammation (swelling or tenderness) of the liver. Hepatitis C virus (HCV) is the most common form of viral hepatitis and usually

More information

Hepatitis C Best Practice Guidelines For Local Health Departments

Hepatitis C Best Practice Guidelines For Local Health Departments Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have

More information

Epidemiology and Screening for Hepatitis C Infection

Epidemiology and Screening for Hepatitis C Infection Epidemiology and Screening for Hepatitis C Infection Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Epidemiology/Screening for Hepatitis

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #400 (NQF 3059): One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Strategies to Address HCV

Strategies to Address HCV Strategies to Address HCV HIV Programs & U.S. Viral Hepatitis Action Plan Corinna Dan, RN, M.P.H. Viral Hepatitis Policy Advisor Office of HIV/AIDS and Infectious Disease Policy September 10, 2015 1 The

More information

Hepatitis C Virus (HCV)

Hepatitis C Virus (HCV) Clinical Practice Guidelines Hepatitis C Virus (HCV) OBJECTIVE The purpose is to guide the appropriate diagnosis and management of Hepatitis C Virus (HCV). GUIDELINE These are only guidelines, and are

More information

Hepatitis C SYMPTOMS COMPLICATIONS

Hepatitis C SYMPTOMS COMPLICATIONS Hepatitis C Hepatitis simply means "inflammation of the liver". Hepatitis C is a virus that was isolated in 1989. Since then, a tremendous amount has been learned about the virus. SYMPTOMS Hepatitis C

More information

High Yield and Feasibility of Baby Boomer Birth Cohort HCV Screening in Two Urban, Academic Emergency Departments

High Yield and Feasibility of Baby Boomer Birth Cohort HCV Screening in Two Urban, Academic Emergency Departments High Yield and Feasibility of Baby Boomer Birth Cohort HCV Screening in Two Urban, Academic Emergency Departments James W Galbraith, MD 1 ; Jordan Morgan, MPH 1 ; Joel Rodgers, MPH 1 ; Ricardo Franco,

More information

SUBJECT: Hepatitis C Virus (HCV) Counseling/Education, Testing, Referral, and Partner Notification

SUBJECT: Hepatitis C Virus (HCV) Counseling/Education, Testing, Referral, and Partner Notification SUBJECT: Hepatitis C Virus (HCV) Counseling/Education, Testing, Referral, and Partner Notification Hepatitis C virus (HCV) infection is the most common chronic bloodborne infection in the United States.

More information

Definition: Active injection drug users - Those who have injected any drug(s) within the 12 month reporting period

Definition: Active injection drug users - Those who have injected any drug(s) within the 12 month reporting period Quality ID #387 (NQF 3060): Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL

More information

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10 13, 2016

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10 13, 2016 Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10 13, 2016 Disclosures: Hep C Update N. Randy Kolb, MD Speakers has received Funding

More information

WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT

WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT October 13, 2016 Reminder - treatment is recommended for all patients with chronic HCV infection Except short life expectancies that cannot be remediated

More information

Hepatitis C. No disclosures. 1. The USPSTF recommends Hepatitis C screening in which patient populations?

Hepatitis C. No disclosures. 1. The USPSTF recommends Hepatitis C screening in which patient populations? Hepatitis C Jennifer Acosta PA-C No disclosures 1. The USPSTF recommends Hepatitis C screening in which patient populations? a. All adults at least once b. Immigrants to the US and those over age 65 c.

More information

Welcome to Your Reading Assignment

Welcome to Your Reading Assignment Welcome to Your Reading Assignment This workbook contains four reading assignments. It is filled with easy-to-read articles you can use to help keep yourself and those you care about safe. After each reading

More information

Hepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003

Hepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003 Hepatitis 2003 STARS Program Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003 Outline n Hepatitis A Epidemiology and screening Transmission n Hepatitis B Epidemiology

More information

SCREEN, TREAT, OR PREVENT HCC:

SCREEN, TREAT, OR PREVENT HCC: SCREEN, TREAT, OR PREVENT HCC: Liver Cancer Prevention in Texas Baby Boomers Barbara J Turner MD, MSEd Founding Director, Center for Research to Advance Community Health University of Texas Health San

More information

INTEGRATED HCV SCREENING AND TESTING IN SUBSTANCE ABUSE TREATMENT

INTEGRATED HCV SCREENING AND TESTING IN SUBSTANCE ABUSE TREATMENT INTEGRATED HCV SCREENING AND TESTING IN SUBSTANCE ABUSE TREATMENT HEPATITIS Hepatitis is the name for a family of viral infections that affect the liver. The most common types are Hepatitis A, B, and C.

More information

Hepatitis C. David Byers, MD, FACP Senior Medical Director for Infectious Diseases and Wound Healing Services Southern Ohio Medical Center

Hepatitis C. David Byers, MD, FACP Senior Medical Director for Infectious Diseases and Wound Healing Services Southern Ohio Medical Center Hepatitis C David Byers, MD, FACP Senior Medical Director for Infectious Diseases and Wound Healing Services Southern Ohio Medical Center DISCLOSURE The speaker and members of the planning committee do

More information

i Screening and Natural History

i Screening and Natural History HCV Epidemiology, i Screening and Natural History BRUCE A. LUXON, MD, PHD, FACG ANTON AND MARGARET FUISZ CHAIR IN MEDICINE PROFESSOR AND CHAIRMAN DEPARTMENT OF MEDICINE GEORGETOWN UNIVERSITY Hepatitis

More information

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38 2016 Annual Morbidity Report HEPATITIS C, ACUTE a Rates calculated based on less than 19 cases or events are considered unreliable b Calculated from: CDC. Notice to Readers: Final 2016 Reports of Nationally

More information

Commonly Asked Questions About Chronic Hepatitis C

Commonly Asked Questions About Chronic Hepatitis C Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral

More information

Prevent Hepatocellular Carcinoma through Screening, Vaccination, and Treatment of Viral Hepatitis Milena Gould Suarez, MD

Prevent Hepatocellular Carcinoma through Screening, Vaccination, and Treatment of Viral Hepatitis Milena Gould Suarez, MD Prevent Hepatocellular Carcinoma through Screening, Vaccination, and Treatment of Viral Hepatitis Milena Gould Suarez, MD Hello, my name is Milena Gould Suarez, and today I will present "Prevent Hepatocellular

More information

Part I. Prior Authorization Criteria and Policy

Part I. Prior Authorization Criteria and Policy Texas Vendor Drug Program Antiviral Agents for Hepatitis C Virus Initial Authorization Request (Medicaid) Part I. Prior Authorization Criteria and Policy March 2018-E I. Eligibility 1. Patient is enrolled

More information

Molina Healthcare of Texas Hepatitis C Drugs (Medicaid)

Molina Healthcare of Texas Hepatitis C Drugs (Medicaid) Texas Standard Prior Authorization Form Addendum Molina Healthcare of Texas Hepatitis C Drugs (Medicaid) This fax machine is located in a secure location as required by HIPAA Regulations. Complete / Review

More information

Transmission/Prevention

Transmission/Prevention Transmission/Prevention Section Three Transmission/Prevention Hepatitis C is transmitted by blood-to-blood contact. Any break in the skin may allow HCV to enter the body, even if no blood is visible. The

More information

WHAT IS HEPATITIS C? 2 DOES HEPATITIS C AFFECT PREGNANCY? HOW DO I GET TREATED FOR HEPATITIS C?

WHAT IS HEPATITIS C? 2 DOES HEPATITIS C AFFECT PREGNANCY? HOW DO I GET TREATED FOR HEPATITIS C? 1 TABLE OF CONTENTS WHAT IS HEPATITIS C? 2 HOW DO PEOPLE GET INFECTED WITH HEPATITIS C? 4 HOW DOES HEPATITIS C AFFECT MY BODY? 6 DOES HEPATITIS C AFFECT PREGNANCY? 8 HOW DO I GET TESTED FOR HEPATITIS C?

More information

Hepatitis C Infection: Updated Information for Front Line Workers in Primary Care Settings MAMTA K. JAIN, MD, MPH 2/14/18

Hepatitis C Infection: Updated Information for Front Line Workers in Primary Care Settings MAMTA K. JAIN, MD, MPH 2/14/18 Hepatitis C Infection: Updated Information for Front Line Workers in Primary Care Settings MAMTA K. JAIN, MD, MPH 2/14/18 Overview Hepatitis C Virus Prevalence Effects of Hepatitis C Prevention Diagnosis

More information

Practical Solutions to Reduce Incidence of Liver Cancer. Nancy Steinfurth, Executive Director Liver Health Connection November 2017

Practical Solutions to Reduce Incidence of Liver Cancer. Nancy Steinfurth, Executive Director Liver Health Connection November 2017 Practical Solutions to Reduce Incidence of Liver Cancer Nancy Steinfurth, Executive Director Liver Health Connection November 2017 Prevention HBV Vaccinate for hepatitis B Costs between $120 and $370 if

More information

Routinizing HIV and HCV Testing Using an Innovative, Scalable and Sustainable Dual Testing Model

Routinizing HIV and HCV Testing Using an Innovative, Scalable and Sustainable Dual Testing Model Routinizing HIV and HCV Testing Using an Innovative, Scalable and Sustainable Dual Testing Model Catelyn Coyle MPH, MEd Public Health National Symposium June 2014 Outline Background Description of model

More information

Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT

Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT Background and affiliations BS (MIT); 3 years in international health (Mexico City and Honduras with Peace Corps); MS (Colorado State University);

More information

ADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES

ADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES ADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES David Njabulo Whiters, PhD, MSW, NCAC II Consultant, Great Lakes Addiction Technology Transfer Center Setting

More information

Stop HCC THE CASE FOR HEPATITIS C SCREENING OF BABY BOOMERS TO PREVENT LIVER FAILURE AND CANCER

Stop HCC THE CASE FOR HEPATITIS C SCREENING OF BABY BOOMERS TO PREVENT LIVER FAILURE AND CANCER Stop HCC THE CASE FOR HEPATITIS C SCREENING OF BABY BOOMERS TO PREVENT LIVER FAILURE AND CANCER BARBARA J TURNER, MD, MSED J a m e s D a n d O n a I D y e P r o f e s s o r o f M e d i c i n e D i r e

More information

Management of Chronic HCV 2017 and Beyond

Management of Chronic HCV 2017 and Beyond Management of Chronic HCV 2017 and Beyond Blaire E Burman, MD Virginia Mason Gastroenterology & Hepatology Relevant Disclosures No financial disclosures to report Leaning Objectives Burden of HCV Prevalence

More information

Hepatitis C: Let s Talk About It. Causes of Hepatitis

Hepatitis C: Let s Talk About It. Causes of Hepatitis Hepatitis C: Let s Talk About It Susan Thompson, RN, MPH Technical Assistance and Training Program NC Communicable Disease Branch July 2012 Causes of Hepatitis any swelling, inflammation, or irritation

More information

STOP Hepatocellular Carcinoma

STOP Hepatocellular Carcinoma STOP Hepatocellular Carcinoma Laura Tenner MD MPH, Amit G. Singal MD MS, Mamta Jain MD, Barbara Turner MD, Barbara Riske MS ReACH Center and Dept of Medicine UT Health San Antonio Dept of Medicine UT Southwestern

More information

Updates in the Treatment of Hepatitis C

Updates in the Treatment of Hepatitis C Disclosures Updates in the Treatment of Hepatitis C Arslan Kahloon M.D Assistant Professor of Medicine University of Tennessee, Chattanooga I have no conflicts of interest or financial sponsorship to disclose

More information

NIH Consensus Conference Statement. Management of Hepatitis C. March 24-26, NIH Web site. Available at:

NIH Consensus Conference Statement. Management of Hepatitis C. March 24-26, NIH Web site. Available at: ABC s of Hepatitis C Treatment Today Elizabeth N. Britton, MSN, FNP-BC Hepatology Services Louisiana State University Health Sciences Center ebritt@lsuhsc.edu ANAC CONFERENCE -TUCSON NOV 2012 Hepatitis

More information

X-Plain Hepatitis B Reference Summary

X-Plain Hepatitis B Reference Summary X-Plain Hepatitis B Reference Summary Introduction Hepatitis B is the most common serious liver infection. It is caused by the hepatitis B virus that attacks the liver. The virus is transmitted through

More information

HEPATITIS C. The Facts

HEPATITIS C. The Facts HEPATITIS C The Facts Your liver keeps you healthy in many ways, such as by removing toxins from your blood and transforming nutrients from food into energy. Hepatitis means inflammation of the liver.

More information

Project SUCCEED Scaling up Co Infection Care & Eliminating Ethnic Disparities 13 th Annual Iris House Women As the Face of AIDS Summit May 7th, 2018

Project SUCCEED Scaling up Co Infection Care & Eliminating Ethnic Disparities 13 th Annual Iris House Women As the Face of AIDS Summit May 7th, 2018 Project SUCCEED Scaling up Co Infection Care & Eliminating Ethnic Disparities 13 th Annual Iris House Women As the Face of AIDS Summit May 7th, 2018 2 Project SUCCEED Team Natalie Octave, MPH, CHES Project

More information

Hepatitis C Virus (HCV) & Infectious Disease 101 for Hubs & Spokes April 24, :00 pm 1:00 pm

Hepatitis C Virus (HCV) & Infectious Disease 101 for Hubs & Spokes April 24, :00 pm 1:00 pm Hepatitis C Virus (HCV) & Infectious Disease 101 for Hubs & Spokes April 24, 2018 12:00 pm 1:00 pm Presenters: Thomas E. Freese, PhD, Larissa Mooney, MD, & Rachel McLean, MPH, Chief, Office of Viral Hepatitis

More information

HEPATITIS C BASICS ILAN S. WEISBERG, MD DIRECTOR HEPATOLOGY LENOX HILL HOSPITAL JUNE 20, 2015

HEPATITIS C BASICS ILAN S. WEISBERG, MD DIRECTOR HEPATOLOGY LENOX HILL HOSPITAL JUNE 20, 2015 HEPATITIS C BASICS ILAN S. WEISBERG, MD DIRECTOR HEPATOLOGY LENOX HILL HOSPITAL JUNE 20, 2015 Overview Understand the GLOBAL and US burden of chronic HCV infec

More information

Welcome to the Hepatitis C Education Class

Welcome to the Hepatitis C Education Class Welcome to the Hepatitis C Education Class Topics of the Class Your liver Types of hepatitis How hepatitis C is spread How to protect your liver Treatment for hepatitis C What is the Liver? Makes chemicals

More information

Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER

Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER Objective Epidemiology Screening criteria Appropriate work up Treatment Guidelines

More information

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Hepatitis B: A Preventable Cause of Liver Cancer Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Overview Epidemiology HBV and cancer Screening, Diagnosis

More information

Increasing Hepatitis C Knowledge for Behavioral Health and Medical Providers

Increasing Hepatitis C Knowledge for Behavioral Health and Medical Providers Increasing Hepatitis C Knowledge for Behavioral Health and Medical Providers Diana Padilla, Program Manager, NDRI-USA Hepatitis C Specialist, NeC ATTC 1 HCV Disease Burden and Populations at Risk 2 Hepatitis

More information

Zobair M. Younossi M.D., M.P.H., FACG

Zobair M. Younossi M.D., M.P.H., FACG HCV Epidemiology and Cohort Screening Guidelines Zobair M. Younossi, MD, MPH, FACG Consultant or Advisor: Conatus, Enterome, Gilead, Merck, Salix, Vertex, J & J HCV Epidemiology and Cohort Screening Guidelines

More information

Hepatitis C (HCV) Digestive Health Recognition Program

Hepatitis C (HCV) Digestive Health Recognition Program PQRS #84 Hepatitis C: Ribonucleic Acid (RNA) Effective Clinical Process NQF 0395 Testing Before Initiating Treatment Care Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis

More information

You, Your Liver and Hepatitis C

You, Your Liver and Hepatitis C You, Your Liver and Hepatitis C Hilda Ortiz-Morales NP, PhD Montefiore Medical Center HIV-HCV Program Coordinator New York State Department of Health Anatomy Function Absorbs good nutrients Stores sugar

More information

Hepatocellular carcinoma

Hepatocellular carcinoma Hepatocellular carcinoma Mary Ann Y. Huang, M.D., M.S., FAASLD Transplant hepatologist Peak Gastroenterology Associates Porter Adventist Hospital Denver, Colorado Background - Worldwide Hepatocellular

More information

PHILLY HEPATITIS ANSWERS ABOUT HEPATITIS

PHILLY HEPATITIS ANSWERS ABOUT HEPATITIS PHILLY HEPATITIS ANSWERS ABOUT HEPATITIS TABLE OF CONTENTS WHAT IS HEPATITIS B? 2 HOW DO PEOPLE GET INFECTED WITH HEPATITIS B? 4 HOW DOES HEPATITIS B AFFECT MY BODY? 6 DOES HEPATITIS B AFFECT PREGNANCY?

More information

Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention

Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Time to Eliminate Hepatitis B John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and

More information

HEPATITIS C. Whitney Dickson, PharmD, BCPS October 12 th, 2017

HEPATITIS C. Whitney Dickson, PharmD, BCPS October 12 th, 2017 HEPATITIS C Whitney Dickson, PharmD, BCPS October 12 th, 2017 MY BACKGROUND Pharmacy School: University of California San Diego Pharmacy Practice Residency (PGY1): University of Illinois at Chicago HIV/Hep

More information

Before we begin. If you received a white card when you came in please read it and answer this question: What is the risk of Hep C with this activity?

Before we begin. If you received a white card when you came in please read it and answer this question: What is the risk of Hep C with this activity? Before we begin If you received a white card when you came in please read it and answer this question: What is the risk of Hep C with this activity? Put your white card under the appropriate sign at the

More information

26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges

26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges Rate per, Types of Viral Hepatitis A E B D C Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges Source of virus Feces Feces Blood/bloodderived body fluids

More information

Greater Glasgow and Clyde. Blood Borne Viruses: Some important basic facts

Greater Glasgow and Clyde. Blood Borne Viruses: Some important basic facts Greater Glasgow and Clyde Blood Borne Viruses: Some important basic facts Greater Glasgow and Clyde Blood Borne Viruses: Some important basic facts A programme developed by Greater Glasgow and Clyde Health

More information

Hepatitis C. Living with a Silent, Chronic Disease

Hepatitis C. Living with a Silent, Chronic Disease Hepatitis C Living with a Silent, Chronic Disease Is Hepatitis C Like Other Kinds of Hepatitis? Hepatitis means inflammation of the liver. Hepatitis can be caused by many things, such as alcohol or certain

More information

Hepatitis C in the United States : Preparing for the Test and Cure Era

Hepatitis C in the United States : Preparing for the Test and Cure Era Hepatitis C in the United States : Preparing for the Test and Cure Era Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Centers for Disease Control and Prevention

More information

Digestive & Liver Disease Wellness

Digestive & Liver Disease Wellness Digestive & Liver Disease Wellness Colorectal Cancer Screening & Prevention According to the American Cancer Society, this year 136,830 people in the U.S. According will be to diagnosed the American with

More information

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States

More information

Agenda. Hepatitis C: Evaluation & Treatment. Background. Natural History of Hepatitis C. Epidemiology 9/23/2014

Agenda. Hepatitis C: Evaluation & Treatment. Background. Natural History of Hepatitis C. Epidemiology 9/23/2014 Hepatitis C: Evaluation & Treatment Amanda DeVoss, MMS, PA-C WAPA Conference Fall 2014 adevoss@wisc.edu Background Epidemiology Transmission Screening Agenda Diagnosis Evaluation Treatment Background Natural

More information

HCV: Racial Disparities. Charles D. Howell, M.D., A.G.A.F Professor of Medicine University of Maryland School of Medicine Baltimore, MD

HCV: Racial Disparities. Charles D. Howell, M.D., A.G.A.F Professor of Medicine University of Maryland School of Medicine Baltimore, MD HCV: Racial Disparities Charles D. Howell, M.D., A.G.A.F Professor of Medicine University of Maryland School of Medicine Baltimore, MD Charles Howell Disclosures Research Grants Boehringer Ingelheim, Inc.

More information

Introduction and Background

Introduction and Background Table of Contents Preface and Acknowledgements... i Introduction and Background... 1 Testing Session... 10 Antibody Negative/Nonreactive Test Results... 18 Antibody Positive/Reactive Test Result... 25

More information

Hepatitis C. Surveillance Protocol. Infectious Disease Epidemiology Program. Provider Responsibilities

Hepatitis C. Surveillance Protocol. Infectious Disease Epidemiology Program. Provider Responsibilities January 2007 Hepatitis C Provider Responsibilities 1) Report newly diagnosed persons with acute hepatitis C by completing the provider and laboratory (yellow and green) sections of the WVEDSS form. Forward

More information

HCV Testing Challenges & Systems-based Solutions

HCV Testing Challenges & Systems-based Solutions HCV Testing Challenges & Systems-based Solutions Webcast 2.3 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department Communicable Disease Control Program Manager Webcast Overview 1

More information

HEPATITIS C AND CHRONIC KIDNEY DISEASE

HEPATITIS C AND CHRONIC KIDNEY DISEASE Learning About HEPATITIS C AND CHRONIC KIDNEY DISEASE kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney Disease

More information

Hepatitis : A Visual Guide to Hepatitis

Hepatitis : A Visual Guide to Hepatitis Hepatitis : A Visual Guide to Hepatitis What Is Hepatitis? Hepatitis is an inflammation of the liver. It may be caused by drugs, alcohol use, or certain medical conditions. But in most cases, it's caused

More information

HCV Infection in the United States

HCV Infection in the United States New York State Department of Health HCV Infection in the United States ~4 million in the U.S. infected with chronic hepatitis C virus (HCV) 17,000 new infections per year 75 percent of adults with hepatitis

More information

Economic Impact of Hepatitis C: Highlights of Cost-Effectiveness Modeling. Presented at: Viral Hepatitis Action Coalition Biannual

Economic Impact of Hepatitis C: Highlights of Cost-Effectiveness Modeling. Presented at: Viral Hepatitis Action Coalition Biannual Economic Impact of Hepatitis C: Highlights of Cost-Effectiveness Modeling Presented at: Viral Hepatitis Action Coalition Biannual Meeting Atlanta, GA May 15, 2013 Overview Cost-effectiveness review AIM

More information

HCV epi overview. Brigg Reilley, NPAIHB, Nat l Program Epidemiologist,

HCV epi overview. Brigg Reilley, NPAIHB, Nat l Program Epidemiologist, HCV epi overview Brigg Reilley, NPAIHB, Nat l Program Epidemiologist, brigg.reilley@ihs.gov In 20 minutes, we will cover Transmission/trends Screening HCV estimates: national, IHS, OK (federal), Cherokee

More information

What is hepatitis? What is hepatitis A? How is it spread? What are the symptoms? How soon do symptoms appear? How is hepatitis A diagnosed?

What is hepatitis? What is hepatitis A? How is it spread? What are the symptoms? How soon do symptoms appear? How is hepatitis A diagnosed? Hepatitis A Massachusetts Department of Public Health, 305 South Street, Jamaica Plain, MA 02130 What is hepatitis? Hepatitis is any kind of inflammation (a reaction which can include swelling and pain)

More information

Viral Hepatitis. WHO Regional Office for Europe July 2013

Viral Hepatitis. WHO Regional Office for Europe July 2013 Viral Hepatitis WHO Regional Office for Europe July 2013 What is Hepatitis? Hepatitis is a viral infection that causes inflammation of the liver There are five main types of viral hepatitis: A, B, C, D,

More information

HEPATITIS C LESSONS PART 1

HEPATITIS C LESSONS PART 1 What Is Hepatitis C, How Does It Spread and What Are the Symptoms? PURPOSE To provide people in your community some basic facts about hepatitis C, and to educate them about the liver in general; to teach

More information

Hepatitis C Infection and the Opportunity for Eradication

Hepatitis C Infection and the Opportunity for Eradication Hepatitis C Infection and the Opportunity for Eradication Dawn Fishbein, MD, MS Scientific Director, Viral Hepatitis Research MedStar Health Research Institute Women in Government Healthcare Summit November

More information

Hepatitis B. What Is Hepatitis? What Are The Two Stages Of Hepatitis? Published on: 5 Oct 2010

Hepatitis B. What Is Hepatitis? What Are The Two Stages Of Hepatitis? Published on: 5 Oct 2010 Published on: 5 Oct 2010 Hepatitis B What Is Hepatitis? Hepatitis is an inflammation of the liver. Inflammation causes soreness and swelling. Hepatitis can be caused by many things. Hepatitis is most commonly

More information

The facts you need to know

The facts you need to know Hepatitis B The facts you need to know Patient information booklet Know it. Test it. Treat it. Table of contents About this booklet 3 What is hepatitis? 3 What is chronic hepatitis B? 3 Can someone be

More information

Geo-epidemiology of Hepatitis C in Northeast Indiana

Geo-epidemiology of Hepatitis C in Northeast Indiana Geo-epidemiology of Hepatitis C in Northeast Indiana Shori Gerardot, Ashley Cross, Atit Patel, Kassidy Beck MS, Scott M. Stienecker MD, and Teresa A. Beam PhD Hepatitis C (HCV) ~180 million worldwide ~2.7-3.9

More information

Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious Disease & Laboratory Sciences

Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious Disease & Laboratory Sciences Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious

More information

US Proposal to Transform Response to Hepatitis B and C. Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA

US Proposal to Transform Response to Hepatitis B and C. Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA US Proposal to Transform Response to Hepatitis B and C Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA US Proposal to Transform Response to Hepatitis B and C Burden of disease Deficiencies

More information

You re not alone LIVING WITH HEPATITIS C

You re not alone LIVING WITH HEPATITIS C HCV_2063_PIB_E03.indd 1 You re not alone LIVING WITH HEPATITIS C HCV_2063_PIB_E03.indd 2 HAVE HEPATITIS C? READ THIS BROCHURE! And learn more about it. DON T HAVE HEPATITIS C? READ THIS BROCHURE ANYWAY!

More information

Blood Borne Pathogens. Becky Walch, R.N. Micheel Valdez, L.V.N.

Blood Borne Pathogens. Becky Walch, R.N. Micheel Valdez, L.V.N. Blood Borne Pathogens Becky Walch, R.N. Micheel Valdez, L.V.N. Examples of Blood Borne Pathogens Hepatitis B Hepatitis C Other Hepatitis HIV Hepatitis Hepatitis means inflammation of the liver. Hepatitis

More information

Patient-Centered Hepatitis C Virus (HCV) Care Via Telemedicine for Individuals on Opiate Agonist Treatment Marija Zeremski, PhD

Patient-Centered Hepatitis C Virus (HCV) Care Via Telemedicine for Individuals on Opiate Agonist Treatment Marija Zeremski, PhD Patient-Centered Hepatitis C Virus (HCV) Care Via Telemedicine for Individuals on Opiate Agonist Treatment Marija Zeremski, PhD Project Director Clinical Directors Network, Inc. Training Overview Brief

More information

Hepatitis B. What is hepatitis B? How is HBV spread?

Hepatitis B. What is hepatitis B? How is HBV spread? 2015 Hepatitis B Hepatitis B What is hepatitis B? Hepatitis B is a liver condition caused by the hepatitis B virus (HBV). HBV can be chronic, in which case it can lead to liver failure, liver cancer, or

More information

Question 1. Blood Borne Viruses: Some important basic facts 6. What does BBV stand for? A. Blood Based Virus. B. Blood Borne Viruses

Question 1. Blood Borne Viruses: Some important basic facts 6. What does BBV stand for? A. Blood Based Virus. B. Blood Borne Viruses Question 1 What does BBV stand for? A. Blood Based Virus B. Blood Borne Viruses C. Basic Blood Viruses Blood Borne Viruses: Some important basic facts 6 Question 1 What does BBV stand for? A. Blood Based

More information

HIV 101. San Joaquin AIDS Foundation 4330 N. Pershing Ave., Ste. B3 Stockton, CA (209) Fax

HIV 101. San Joaquin AIDS Foundation 4330 N. Pershing Ave., Ste. B3 Stockton, CA (209) Fax HIV 101 Presented By: Daniel Corona San Joaquin AIDS Foundation 4330 N. Pershing Ave., Ste. B3 Stockton, CA 95207 (209) 476-8533 Fax 476-8142 www.sanjoaquinaidsfoundation.org This presentation brought

More information

Is Elimination of Hepatitis C Possible?

Is Elimination of Hepatitis C Possible? Is Elimination of Hepatitis C Possible? JORGE MERA, MD CHEROKEE NATION DISCLOSURE INFORMATION The presenter has nothing to disclose. Outline Scope of the problem Definitions Is elimination of HCV needed?

More information

Overview of Hepatitis C Virus: The Challenge & The Opportunity. Cody A. Chastain, MD

Overview of Hepatitis C Virus: The Challenge & The Opportunity. Cody A. Chastain, MD Overview of Hepatitis C Virus: The Challenge & The Opportunity Cody A. Chastain, MD Disclosures Research supported by Gilead Sciences Inc.: Site investigator for HIV/HCV SWITCH Registry Study Key faculty

More information

Hepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches

Hepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/hepatitis-c-virus-hcvcurrent-screening-guidelines-treatment-approaches/9514/

More information

Bloodborne Pathogens and Universal Precautions

Bloodborne Pathogens and Universal Precautions Bloodborne Pathogens and Universal Precautions Parkway School District 2012-2013 Revised 9/19/2012 What Are Bloodborne Pathogens(BBPs) Bloodborne pathogens (BBPs) are disease causing microorganisms carried

More information

your liver Care for Think about hepatitis

your liver Care for Think about hepatitis your liver Care for Think about hepatitis World Hepatitis Day 2015 What is hepatitis? Hepatitis is the common name for all inflammatory diseases of the liver. Liver inflammation is most often caused by

More information

Viral Hepatitis - Historical Perspective

Viral Hepatitis - Historical Perspective Viral Hepatitis - Historical Perspective Infectious A E Enterically transmitted Viral hepatitis NANB Serum B D F, G,? other C Parenterally transmitted Before the discovery of hepatitis A virus (HAV) and

More information

Hepatitis C in Correctional Facilities: Big Problem, Bigger Opportunity. Cody A. Chastain, MD

Hepatitis C in Correctional Facilities: Big Problem, Bigger Opportunity. Cody A. Chastain, MD Hepatitis C in Correctional Facilities: Big Problem, Bigger Opportunity Cody A. Chastain, MD Disclosures Research supported by Gilead Sciences Inc.: Site investigator for HIV/HCV SWITCH Registry Study

More information

Viral Hepatitis Update: Screening, Vaccination, and Treatment

Viral Hepatitis Update: Screening, Vaccination, and Treatment Viral Hepatitis Update: Screening, Vaccination, and Treatment Alaska Maternal Child Health & Immunization Conference September 28, 2016 Prabhu Gounder, MD, MPH, FACP Medical officer, CDC Arctic Investigations

More information

DIAGNOSIS AN EDUCATIONAL SERIES BROUGHT TO YOU BY GILEAD SCIENCES

DIAGNOSIS AN EDUCATIONAL SERIES BROUGHT TO YOU BY GILEAD SCIENCES UNDERSTANDING YOUR DIAGNOSIS AN EDUCATIONAL SERIES BROUGHT TO YOU BY GILEAD SCIENCES UNDERSTANDING YOUR HEP C DIAGNOSIS LEARN MORE ABOUT HEP C If you ve been diagnosed with chronic (long-lasting) hepatitis

More information

Contents: 7. Transmission 8. Prevention 9. Testing 10. Living with Hepatitis C 11. Treatments 12. Co-infection 13. Support

Contents: 7. Transmission 8. Prevention 9. Testing 10. Living with Hepatitis C 11. Treatments 12. Co-infection 13. Support Contents: 1. Definitions 2. Facts and Figures 3. History 4. The Liver 5. Progression 6. Symptoms 7. Transmission 8. Prevention 9. Testing 10. Living with Hepatitis C 11. Treatments 12. Co-infection 13.

More information

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis

More information

HEPATITIS C TREATMENT UPDATE

HEPATITIS C TREATMENT UPDATE HEPATITIS C TREATMENT UPDATE Hepatitis C: Burden of Disease in USA HCV is generally asymptomatic until advanced liver disease 4.1 million persons ever infected; 3.2 million chronic infections Up to 75%

More information